Skip to main content

Table 1 Leukemic blast percentages in clinical bone marrow samples of the E/R-positive patients during induction therapy determined by flow cytometry

From: Single cell characterization of B-lymphoid differentiation and leukemic cell states during chemotherapy in ETV6-RUNX1-positive pediatric leukemia identifies drug-targetable transcription factor activities

Sample ID Leukemic blast percentage at diagnosis Leukemic blast percentage at day 15 Leukemic blast percentage at day 29
ALL1 94 10 0.3
ALL3 95 74 0.16
ALL8 93 0.93 0.02
ALL9 79 0.17 0.01
ALL10 65 10 0.08
ALL12 90 59 0.2
ALL7 27 0 0
ALL13 80 0.04 0